{
    "2019-09-24": [
        [
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报:创新主题再次成为热点,坚守“创新+升级”主线",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新",
                        "热点",
                        "升级"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业:药监局发布NSCLC临床试验终点指导原则",
                "features": {
                    "keywords": [
                        "医药生物",
                        "药监局",
                        "NSCLC",
                        "临床试验",
                        "指导原则"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}